Skip to main content
Clinical Trials/JPRN-jRCTs021180004
JPRN-jRCTs021180004CompletedPhase 2

Evaluation of effectiveness of BBG in vitreoretinal surgeries - EEBVS

Abe Samae0 sites187 target enrollmentStarted: March 13, 2019Last updated:
Conditions

Trial Snapshot

Phase
Phase 2
Status
Completed
Sponsor
Enrollment
187

Study Overview

Brief Summary

Surgery with intraocular staining with Brilliant Blue G significantly improved postoperative visual acuity and macular retinal morphology.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
ot applicable to ot applicable (—)
Sex
All

Inclusion Criteria

  • Needs of use of Brilliant blue G in cataract or vitreous surgery

Exclusion Criteria

  • Without severe ocular infections

Investigators

Sponsor
Abe Samae

Similar Trials

Effectiveness of BBG | Clinical Trial